Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by rtftech16on Jun 19, 2018 2:25pm
137 Views
Post# 28193294

RE:RE:Out completely

RE:RE:Out completelyDisclosure: The following message is my personal view. It is not meant to mislead people or promote untrue facts. Everyone should perform their own due dilligence or hire a professional to advise them when making financial decisions. : 

I am excited and very happy I am in GUD.

These overvalued companies you see with rising stock prices have only "grown" because they get cheap debt to fund their operations and increase their purchasing power. It is not real growth. 

Just as we have hit the peak of real estate overvaluation and public company overvaluation in multiple markets across the globe, these companies and consumers will reach a point where they will have to sell their overvalued assets to pay off the debt that they went into to get those assets (which is a vicious cycle that drove asset prices up and thus they became overvalued). They will not be able to fund the debt as interest rates rise and will be forced to sell. 

Low interest debt does not last forever, interest rates are finally starting to rise and will do so fast imo. 

The returns on assets nowadays funded by high levels of low cost debt are diminishing to less than the financing costs of that debt, a peak is nearing. 

Knight and the team are incredibly patient and smart and don't listen to less intelligent humans who don't know how to value an asset and try to just get in on something for short term gain (herd mentality). 

The herd is heading for a cliff. 

Could be this year could be next could be in 5 years or more. Its not if, its when. 

Eventually debt will force companies and consumers to sell their overvalued assets and once the selloff occurs there won't be any buyers until a bottom is reached.

That is what GUD is waiting for in order to buy major assets at prices that make sense.

History repeats itself because the majority of humans never learn and are not intelligent. 

//

END OF MESSAGE
Bullboard Posts